Dolutegravir/dolutegravir/lamivudine/tenofovir/rifampicinLiver injury, renal dysfunction and an increase in serum creatinine: 3 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-04627-9
中图分类号
学科分类号
摘要
引用
收藏
页码:143 / 143
相关论文
共 50 条
  • [46] Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
    Rotea-Salvo, Sandra
    Martinez-Pradeda, Alejandro
    Fernandez-Oliveira, Carla
    Gimenez-Arufe, Victor
    Balboa-Barreiro, Vanesa
    Margusino-Framinan, Luis
    Mena-De-Cea, Alvaro
    Vazquez-Rodriguez, Pilar
    Castro-Iglesias, Angeles
    Lopez-Calvo, Soledad
    Martin-Herranz, Isabel
    Miguez-Rey, Enrique
    Cid-Silva, Purificacion
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (04) : 221 - 226
  • [48] Assessments of very low level HIV replication for dolutegravir plus lamivudine (DTG+3TC) vs dolutegravir plus tenofovir disoproxil/emtricitabine (DTG plus TDF/FTC) in the GEMINI 1&2 studies through week 96
    Underwood, M.
    Urbaityte, R.
    Wang, R.
    Tenorio, A.
    Wynne, B.
    Pappa, K.
    Koteff, J.
    Gartland, M.
    Van Wyk, J.
    Man, C.
    Sievers, J.
    HIV MEDICINE, 2019, 20 : 23 - 23